| Previous Close | 0.2870 |
| Open | 0.2850 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2850 - 0.3998 |
| 52 Week Range | 0.2600 - 1.3500 |
| Volume | 1,040,286 |
| Avg. Volume | 233,771 |
| Market Cap | 50.3M |
| Beta (3Y Monthly) | -0.44 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4130 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LAS VEGAS, NV , Feb. 22, 2019 /CNW/ - Canaccord Genuity, the largest independent investment dealer in Canada , has initiated research coverage of CLS Holdings USA Inc. (CLSH) The initiation report is 38 pages in length and goes into great detail about the $1.1B market opportunity, the competitive positioning of the company, the business overview, valuation, and senior management. The report was created by Bobby Burleson , Analyst, and Jonathan DeCourcey , Associate.
CLS Holdings USA Inc. (CLSH) (CSE:CLSH.U) “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce that it has been included in the LD Micro Index, effective February 1st, 2019. The LD Micro Index is designed to give the most accurate representation of the intraday activity of micro-cap stocks in North America. LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.
Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area.
Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area.
CLS Holdings USA, Inc. “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce that it has entered into an option (the “Agreement”) to acquire In Good Health, in accordance with the previously executed letter of intent. In Good Health is a licensed medical dispensary in Brockton, Massachusetts. In Good Health is located 25 miles south of downtown Boston and is one of the 48 licensed dispensaries in the state.
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2019) - CLS Holdings USA (CSE: CLSH.U) (OTCQB: CLSH), a diversified cannabis company operating as Cannabis Life Sciences, is one of the latest new listings on the Canadian Securities Exchange. Cannabis Life Sciences is the developer of a patented extraction and conversion methodology that has potential to increase both yield and quality of cannabinoid oils extracted from cannabis plants.InvestmentPitch Media has produced a "video" which provides additional ...
LAS VEGAS , Jan. 7, 2019 /CNW/ - CLS Holdings USA , Inc. "CLS," a diversified cannabis company operating as Cannabis Life Sciences, is pleased to provide a corporate update to highlight its achievements and ongoing activities. The common shares of CLS will commence trading on the Canadian Securities Exchange, or CSE, at the opening of the market on January 7, 2019 under the ticker symbol "CLSH". Cannabis Life Sciences is the developer of a patented extraction and conversion methodology that has potential to increase both yield and quality of cannabinoid oils extracted from cannabis plants. CLS recently expanded its business strategy to include cultivation, production, and retail dispensaries, through the acquisition of Oasis Cannabis, a Las Vegas based vertically integrated cannabis company.
CLS Holdings USA, Inc. (CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries, today announced the following shareholder letter from its Chairman and CEO, Jeff Binder. Let me begin by saying it has been an honor and a privilege to lead this young, rapidly growing Cannabis Company. This year marked the initiation of CLS becoming a revenue producing company.
Chairman and CEO, Jeffrey Binder, joined host Everett Jolly to discuss their planned Massachusetts expansion and expected revenue in 2019. Jolly began the interview by inquiring about a recent rumor that the Company may soon be trading on the CSE.
CLS Holdings USA, Inc. (CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries, today is pleased to provide an update on its recent business initiatives in Nevada and Massachusetts. CLS has loaned $5 million to In Good Health, a licensed medical dispensary in Brockton, Massachusetts with a significant market share. In Good Health is located 25 miles south of downtown Boston and is one of the 38 licensed dispensaries in the state.
CLS Holdings USA, Inc. (CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries, today announced the closing of an approximately $12 million private placement (the “Offering”) of 8% senior unsecured convertible debentures (the “Convertible Debentures”). The Offering, conducted by a syndicate of underwriters, was priced at $1,000 per convertible debenture. The Convertible Debentures are convertible into units (each, a “Unit”) at a price of $0.80 per Unit.
Mr. Glashow shares with us his vision of Company's growth and why he believes 2018 and 2019 are essential years for CLS Holdings USA Inc. The interview provides unique insight into the Company's latest corporate developments, updates on recently-achieved milestones, current expansion plans in Nevada and Massachusetts. Additionally, Director Glashow provides his perspective on how CLS Holdings USA Inc. is well positioned to build upon its current technologies and acquisitions strategy in the hyper growth space of the Legal Medical and Recreational Cannabis sectors.